Manufacturing breakthroughs are set to transform cell therapy production, paving the way for faster trials and wider patient …
Manufacturing breakthroughs are set to transform cell therapy production, paving the way for faster trials and wider patient …
Despite economic caution, pharma and biotech leaders invest boldly to reshape pipelines and accelerate innovation.
With fresh capital and a new pipeline strategy, Replicor aims to tackle chronic viral infections and rare liver …
ExoGene’s novel delivery platform earns RMAT status for its lead candidate EXG-401, targeting neuroinflammation and motor neuron survival …
Personalized mRNA cancer vaccine combined with Keytruda delivers sustained recurrence-free survival in high-risk melanoma patients, reinforcing immunotherapy’s future.
Already a subscriber? Log in